[Oral Smeglutide was approved for marketing in China] On January 26, Novo Nordisk Smeglutide tablets were approved for marketing by the National Drug Administration (NMPA) for the treatment of type 2 ...

Reporters learned from the State Food and Drug Administration on January 26 that Novo Nordisk Megglutide Tablets have been approved by the State Food and Drug Administration (NMPA) for marketing to t ...

On January 26, the information released by the National Drug Administration (NMPA) showed that Smeaglutide Tablets under Novo Nordisk (China) Pharmaceutical Co., Ltd. was approved for listing to trea ...